Search

everythinglearnresearchcommunity

for

Search:↓

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

SPT6 prevents excessive skin inflammation by blocking a feedback loop.

The LTF gene may help predict and manage nonspecific orbital inflammation.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Hair follicle cells help protect against immune attacks by regulating T-cell activity.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Interleukin-1 increases keratin K6 production in skin cells.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

miR-5110 affects alpaca pigmentation by altering specific gene expressions.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

Genes affect cytokine production, which can influence chronic diseases, and certain interventions may help prevent related molecular damage.

Targeting CD169+ skin macrophages may help treat psoriasis.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.